Takeda and Endo hit with pay-for-delay claims

Takeda Pharmaceutical and Endo International are facing a lawsuit over an alleged scheme to block generic competition to Takeda’s branded anti-constipation drug Amitiza.


Get unlimited access to all Global Competition Review content